Found: 43
Select item for more details and to access through your institution.
Impact of overexpression of Sushi repeat-containing protein X-linked 2 gene on outcomes of gastric cancer.
- Published in:
- Journal of Surgical Oncology, 2014, v. 109, n. 8, p. 836, doi. 10.1002/jso.23602
- By:
- Publication type:
- Article
Hepatic failure in pregnancy successfully treated by online hemodiafiltration: Chronic hepatitis B virus infection without viral genome mutation.
- Published in:
- Hepatology Research, 2013, v. 43, n. 12, p. 1356, doi. 10.1111/hepr.12090
- By:
- Publication type:
- Article
Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C.
- Published in:
- Hepatology Research, 2013, v. 43, n. 9, p. 919, doi. 10.1111/hepr.12037
- By:
- Publication type:
- Article
Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.843680
- By:
- Publication type:
- Article
Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting.
- Published in:
- Journal of Digestive Diseases, 2015, v. 16, n. 3, p. 143, doi. 10.1111/1751-2980.12221
- By:
- Publication type:
- Article
JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression.
- Published in:
- Gastroenterology Research & Practice, 2017, p. 1, doi. 10.1155/2017/5728946
- By:
- Publication type:
- Article
Midterm Outcomes in Patients With Intermediate-Sized Hepatocellular Carcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 23, p. 5452, doi. 10.1002/cncr.25314
- By:
- Publication type:
- Article
Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents.
- Published in:
- Abdominal Imaging, 2015, v. 40, n. 6, p. 1821, doi. 10.1007/s00261-014-0332-5
- By:
- Publication type:
- Article
High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomas.
- Published in:
- Abdominal Imaging, 2013, v. 38, n. 6, p. 1263, doi. 10.1007/s00261-013-0010-z
- By:
- Publication type:
- Article
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257166
- By:
- Publication type:
- Article
Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B.
- Published in:
- JGH Open, 2021, v. 5, n. 1, p. 34, doi. 10.1002/jgh3.12443
- By:
- Publication type:
- Article
Comparison Between Low Mechanical Index and High Mechanical Index Contrast Modes of Contrast‐Enhanced Ultrasonography: Evaluation of Perfusion Defects of Hypervascular Hepatocellular Carcinomas During the Post–Vascular Phase.
- Published in:
- Journal of Ultrasound in Medicine, 2019, v. 38, n. 9, p. 2329, doi. 10.1002/jum.14926
- By:
- Publication type:
- Article
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 851, doi. 10.1007/s40121-020-00329-y
- By:
- Publication type:
- Article
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 807, doi. 10.1111/jvh.13717
- By:
- Publication type:
- Article
Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 3, p. 470, doi. 10.3109/s10165-011-0521-9
- By:
- Publication type:
- Article
Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 5, p. N.PAG, doi. 10.1093/ofid/ofz185
- By:
- Publication type:
- Article
Drug-induced liver injury after allogeneic bone marrow transplantation.
- Published in:
- 2013
- By:
- Publication type:
- Report
Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study.
- Published in:
- Cancer Science, 1999, v. 90, n. 4, p. 367, doi. 10.1111/j.1349-7006.1999.tb00756.x
- By:
- Publication type:
- Article
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.
- Published in:
- Journal of Clinical & Translational Hepatology, 2024, v. 12, n. 7, p. 646, doi. 10.14218/JCTH.2024.00089
- By:
- Publication type:
- Article
The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma.
- Published in:
- Abdominal Radiology, 2021, v. 46, n. 6, p. 2527, doi. 10.1007/s00261-020-02881-0
- By:
- Publication type:
- Article
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12076-w
- By:
- Publication type:
- Article
Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 5, p. 321, doi. 10.3390/diagnostics10050321
- By:
- Publication type:
- Article
Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 69, doi. 10.1093/jjco/hyq145
- By:
- Publication type:
- Article
Establishment of nomogram prediction model of contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for vessels encapsulating tumor clusters pattern of hepatocellular carcinoma.
- Published in:
- BioScience Trends, 2024, v. 18, n. 3, p. 277, doi. 10.5582/bst.2024.01112
- By:
- Publication type:
- Article
Pretreatment gamma‐glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.
- Published in:
- Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 2, p. 188, doi. 10.1002/kjm2.12771
- By:
- Publication type:
- Article
A new device for fiducial registration of image-guided navigation system for liver RFA.
- Published in:
- International Journal of Computer Assisted Radiology & Surgery, 2018, v. 13, n. 1, p. 115, doi. 10.1007/s11548-017-1647-9
- By:
- Publication type:
- Article
REQUIRED CONDITIONS FOR PATIENT AND TRANSFUSION MANAGEMENT SYSTEMS COMPATIBLE WITH COMPUTER CROSSMATCH-2nd EDITION).
- Published in:
- Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi, 2024, v. 70, n. 1, p. 7
- By:
- Publication type:
- Article
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 1054, doi. 10.1002/cam4.1998
- By:
- Publication type:
- Article
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 6, p. 1190, doi. 10.1111/jgh.16537
- By:
- Publication type:
- Article
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 949, doi. 10.1111/jgh.16494
- By:
- Publication type:
- Article
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1420, doi. 10.1111/jgh.14982
- By:
- Publication type:
- Article
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 7, p. 1229, doi. 10.1111/jgh.14965
- By:
- Publication type:
- Article
Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 5, p. 855, doi. 10.1111/jgh.14874
- By:
- Publication type:
- Article
The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1230, doi. 10.1111/apt.15218
- By:
- Publication type:
- Article
A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/Velpatasvir.
- Published in:
- Case Reports in Gastroenterology, 2021, v. 15, n. 1, p. 436, doi. 10.1159/000511749
- By:
- Publication type:
- Article
Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.
- Published in:
- International Journal of Clinical Oncology, 2012, v. 17, n. 4, p. 373, doi. 10.1007/s10147-011-0306-3
- By:
- Publication type:
- Article
Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
- Published in:
- 2010
- By:
- Publication type:
- Report
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 235, doi. 10.1111/hepr.13739
- By:
- Publication type:
- Article
Circulating microRNA‐1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 7, p. 810, doi. 10.1111/hepr.13338
- By:
- Publication type:
- Article
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognosis following non-surgical second treatment in patients with recurrent hepatocellular carcinoma after percutaneous ablation therapy.
- Published in:
- Liver International, 2009, v. 29, n. 3, p. 443, doi. 10.1111/j.1478-3231.2008.01890.x
- By:
- Publication type:
- Article